Tvardi Therapeutics, Inc. 8-K

What Happened
On January 16, 2026, Tvardi Therapeutics, Inc. announced it made an updated corporate presentation available on its website and furnished that presentation under Regulation FD. The presentation is attached to the Form 8‑K as Exhibit 99.1 and is incorporated by reference.

Key Details

• Date filed: January 16, 2026 (Form 8‑K, Item 7.01, Regulation FD disclosure).
• Exhibit: Corporate Presentation furnished as Exhibit 99.1.
• Availability: Presentation posted on the company’s website and furnished to the SEC.
• Other filing items: Form 8‑K also lists exhibit filings (Item 9.01) but does not report additional material events.

Why It Matters
Furnishing an updated corporate presentation under Regulation FD is a way for the company to share information publicly and ensure broad, fair disclosure. Investors should review the attached presentation for any updates on Tvardi’s strategy, pipeline, milestones, or investor information that could be relevant to investment decisions.